Large Volume Wearable Injectors Market Size & Share, by Product Type (On-Body, Off-Body, Handheld); Device Type (Infusion Pumps, Patch Pumps); Usability (Disposable, Reusable); Therapeutic Area (Cardiovascular Disorders, Infectious Diseases, Neurological Disorders, Oncological Disorders) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4235
  • Published Date: Feb 27, 2023
  • Report Format: PDF, PPT

Top Featured Companies Dominating the Global Large Volume Wearable Injectors Market

top-features-companies
    • Insulet Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Becton, Dickinson, and Company
    • Ypsomed AG
    • Amgen USA Inc.
    • United Therapeutics Corporation
    • West Pharmaceutical Services, Inc.
    • Frederick Furness Publishing Limited
    • Crunchbase, Inc.
    • Eitan Medical Ltd.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Becton, Dickinson, and Company have collaborated with LabCorp, a leading global life sciences company. This collaboration is expected to create a framework to develop, manufacture, and commercialize flow cytometry-based companion diagnostics (CDx) with life-changing treatments for cancer and other diseases.

  • Insulet Corporation announces full market releases of Omnipod 5 Automated Insulin Delivery (AID) System through U.S. retail pharmacy channels for individuals aged six years and older with type 1 diabetes.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4235
  • Published Date: Feb 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increase in deaths by cardiovascular diseases around the world and the burgeoning geriatric population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2023 – 2033.

Extra expenses with the equipment and rising concerns about lack of reimbursement are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Becton, Dickinson and Company, Ypsomed AG, Amgen USA Inc., United Therapeutics Corporation, West Pharmaceutical Services, Inc., Frederick Furness Publishing Limited, Crunchbase, Inc., Eitan Medical Ltd., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, device type, usability, therapeutic area, and by region.

The on-body segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying